Lung Disease With Polymyositis
1 clinical trials · Condition
◉ Watch Lung Disease With Polymyositis
| Record | Firm | Date |
|---|---|---|
| Efficacy and Safety of Longidaza® for the Treatment of Patients With Residual Changes in the Lungs After COVID-19 (NCT06383819) | NPO Petrovax | 2022-04-08 |
Track Lung Disease With Polymyositis automatically
Every clearance here is in the API, with alerts when new ones post.